Transmembrane Protein TMEM230, a Target of Glioblastoma Therapy.

Saved in:
Bibliographic Details
Title: Transmembrane Protein TMEM230, a Target of Glioblastoma Therapy.
Authors: Cocola C; Institute for Biomedical Technologies, National Research Council, Milan, Italy.; Consorzio Italbiotec, Milan, Italy., Magnaghi V; Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy., Abeni E; Institute for Biomedical Technologies, National Research Council, Milan, Italy., Pelucchi P; Institute for Biomedical Technologies, National Research Council, Milan, Italy., Martino V; Institute for Biomedical Technologies, National Research Council, Milan, Italy., Vilardo L; Institute for Biomedical Technologies, National Research Council, Milan, Italy., Piscitelli E; Institute for Biomedical Technologies, National Research Council, Milan, Italy., Consiglio A; Institute for Biomedical Technologies, National Research Council, Milan, Italy., Grillo G; Institute for Biomedical Technologies, National Research Council, Milan, Italy., Mosca E; Institute for Biomedical Technologies, National Research Council, Milan, Italy., Gualtierotti R; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Mazzaccaro D; Operative Unit of Vascular Surgery, IRCCS Policlinico San Donato, San Donato Milanese, Italy., La Sala G; Institute of Biochemistry and Cell Biology, Italian National Research Council, Rome, Italy., Di Pietro C; Institute of Biochemistry and Cell Biology, Italian National Research Council, Rome, Italy., Palizban M; Department of Gynecology and Obstetrics, University Hospital of Münster, Münster, Germany., Liuni S; Institute for Biomedical Technologies, National Research Council, Milan, Italy., DePedro G; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy., Morara S; Institute of Neuroscience, Milan, Italy., Nano G; Operative Unit of Vascular Surgery, IRCCS Policlinico San Donato, San Donato Milanese, Italy.; Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, Italy., Kehler J; National Institutes of Health, NIDDK, Laboratory of Cell and Molecular Biology, Bethesda, MD, United States., Greve B; Department of Radiation Therapy and Radiation Oncology, University Hospital of Münster, Münster, Germany., Noghero A; Lovelace Biomedical Research Institute, Albuquerque, NM, United States.; Department of Oncology, University of Turin, Orbassano, Italy., Marazziti D; Institute of Biochemistry and Cell Biology, Italian National Research Council, Rome, Italy., Bussolino F; Department of Oncology, University of Turin, Orbassano, Italy.; Laboratory of Vascular Oncology Candiolo Cancer Institute - IRCCS, Candiolo, Italy., Bellipanni G; Department of Biology, Center for Biotechnology, Sbarro Institute for Cancer Research and Molecular Medicine, Temple University, Philadelphia, PA, United States., D'Agnano I; Institute for Biomedical Technologies, National Research Council, Milan, Italy., Götte M; Department of Gynecology and Obstetrics, University Hospital of Münster, Münster, Germany., Zucchi I; Institute for Biomedical Technologies, National Research Council, Milan, Italy., Reinbold R; Institute for Biomedical Technologies, National Research Council, Milan, Italy.
Source: Frontiers in cellular neuroscience [Front Cell Neurosci] 2021 Nov 17; Vol. 15, pp. 703431. Date of Electronic Publication: 2021 Nov 17 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101477935 Publication Model: eCollection Cited Medium: Print ISSN: 1662-5102 (Print) Linking ISSN: 16625102 NLM ISO Abbreviation: Front Cell Neurosci Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1662-5102
DOI:10.3389/fncel.2021.703431